AN2 Therapeutics (ANTX)

• Market cap: $135M
• 1 day: -9.19%
• 5 days: 63.58%
• 1 month: 366.04%
• 3 months: 322.22%
• 6 months: 298.39%
• Year to date: 345.05%
• 1 year: 250.35%
• 5 years: -67.92%
• 10 years: -67.92%
• Sector: Healthcare
• Industry: Biotechnology

About: AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Employees: 36